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To examine whether data sourced from electronic medical records (EMR) and a large indus-
trial spectacle lens manufacturing database can estimate refractive error distribution within
large populations as an alternative to typical population surveys of refractive error.
Subjects
A total of 555,528 patient visits from 28 Irish primary care optometry practices between the
years 1980 and 2019 and 141,547,436 spectacle lens sales records from an international
European lens manufacturer between the years 1998 and 2016.
Methods
Anonymized EMR data included demographic, refractive and visual acuity values. Anon-
ymized spectacle lens data included refractive data. Spectacle lens data was separated into
lenses containing an addition (ADD) and those without an addition (SV). The proportions of
refractive errors from the EMR data and ADD lenses were compared to published results
from the European Eye Epidemiology (E3) Consortium and the Gutenberg Health Study
(GHS).
Results
Age and gender matched proportions of refractive error were comparable in the E3 data and
the EMR data, with no significant difference in the overall refractive error distribution (χ2 =
527, p = 0.29, DoF = 510). EMR data provided a closer match to the E3 refractive error distri-
bution by age than the ADD lens data. The ADD lens data, however, provided a closer
approximation to the E3 data for total myopia prevalence than the GHS data, up to age 64.
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Conclusions
The prevalence of refractive error within a population can be estimated using EMR data in
the absence of population surveys. Industry derived sales data can also provide insights on
the epidemiology of refractive errors in a population over certain age ranges. EMR and
industrial data may therefore provide a fast and cost-effective surrogate measure of refrac-
tive error distribution that can be used for future health service planning purposes.
Introduction
Refractive errors occur when the eye does not correctly focus light at the retina which results
in blurred vision. It arises as a result of the eye growing too long (myopia/short sightedness),
the eye not growing long enough (hyperopia/long sightedness), uneven focussing due to cor-
neal shape (astigmatism) or a failure to focus at close ranges due to aging (presbyopia). In
order to obtain clear vision, correction either through the use of optical aids such as spectacles
or contact lenses or refractive surgery is required.
Refractive errors are a leading cause of vision impairment and blindness globally, due to
limited access to optical correction in some regions [1], and the range of ocular diseases for
which refractive errors, in particular myopia, are an identified risk factor [2,3]. There is a
growing concern about myopia due to the rapid rise in global prevalence over the last few
decades [4]. Vitale et al [5] found an increase in myopia prevalence from 25% in 1971–1972 to
41.6% in 1999–2004 in the United States of America. Similar increases have been observed in
Europe, with higher levels of myopia observed in more recent birth cohorts [6]. The largest
increases in myopia prevalence have been observed in Asia [7], particularly east Asia, with
rates reaching 84% in older children [8]. The level of myopia prevalence is not as high in South
America [9,10] or Africa [11], however, it is expected to rise significantly in all parts of the
world in the coming years [4]. Holden et al [4] estimated that almost half of the world’s popu-
lation will be myopic by 2050, with almost 10% set to be highly myopic. The authors extrapo-
lated these myopia rates by using data from published population surveys of refractive error.
The primary limitation identified in this study was the significant lack of global epidemiologi-
cal refractive error data, with many countries having no data whatsoever or significant gaps in
data across different regions, age groups and ethnicities. The authors made specific reference
to the reduced certainty with regards to their high myopia predictions, with only 48 studies
contributing data to these projections.
In order to assess the public health implications of refractive errors, it is essential to have
accurate population-based epidemiological data. In light of the observed differences between
countries and changing prevalence over time, such data needs to be both representative of a
given population and current. In Europe, epidemiological data has been collected over many
decades, often from historical cohorts. The largest such study [12], the European Eye Epidemi-
ology (E3) consortium of 33 groups from 12 European countries, collated data on 124,000
European participants from population cohort and cross-sectional studies on refractive error
conducted between 1990 and 2013. While this data does show a trend of increased myopia
prevalence for people born in more recent decades, the available data from recent years and on
younger population cohorts is relatively sparse.
Gathering comprehensive epidemiological data that can determine global prevalence trends
in refractive error over time using this traditional methodology is slow and open to question in
terms of cost effectiveness [13,14]. For this reason, the growing volume of data gathered in
PLOS ONE Application of big-data for epidemiological studies of refractive error
PLOS ONE | https://doi.org/10.1371/journal.pone.0250468 April 23, 2021 2 / 17
Committee has placed restrictions on
disseminating this data. Data access requests can
be sent to researchethics@tudublin.ie quoting
ethics approval REC-18-124.
Funding: Arne Ohlendorf and Siegfried Wahl are
employees of Carl Zeiss Vision International GmbH.
These authors provided access to some of the data
used in this study and reviewed the work before
submission. The funder provided support in the
form of salaries for authors [AO, SW], but did not
have any additional role in the study design, data
collection and analysis, decision to publish, or
preparation of the manuscript. The specific roles of
these authors are articulated in the ‘author
contributions’ section.
Competing interests: Arne Ohlendorf and Siegfried
Wahl are employees of Carl Zeiss Vision
International GmbH. This does not alter our
adherence to PLOS ONE policies on sharing data
and materials. There are no other competing
interests to declare.
healthcare in recent years is of specific interest. Data such as electronic medical records (EMR)
and industrial manufacturing or sales records represent a potentially valuable source of sec-
ondary data, i.e. data used for a purpose that is different from that for which it was originally
collected. The scale of such data is often far larger than conventional research datasets and it is
now commonly referred to as Big Data. Big Data is now recognized as an important resource
for scientific research, allowing conclusions to be drawn that would otherwise be impossible
using traditional scientific techniques [15,16].
In the field of eyecare, several studies have demonstrated the usefulness of EMR data for
determining disease epidemiology [17,18] and treatment outcomes [19,20]. The application of
such approaches to myopia genetics research has shown strong correlation with the results
obtained using conventional epidemiological research methodologies [21,22]. National [23,24]
and private insurance claims records have also been used to determine the epidemiology of
several ocular diseases, as have hospital records [25]. Big Data sources of this type can be used
as an alternative form of epidemiological data, particularly in the absence of conventional epi-
demiological studies. Datasets such as national insurance claims records can be generalised to
an entire population while EMR and hospital record data are useful when considering specific
population cohorts.
The potential of Big Data as a tool to monitor population trends in refractive error has
received little attention. Optometric EMR data provides an obvious example of a rich source of
data on refractive error that has yet to be exploited for this purpose. Another novel, but less
obvious, source of data is the manufacturing and sales records of companies involved in the
supply of optical appliances such as spectacle and contact lenses. This data source is much
more limited in terms of the information available, but the ubiquity of these optical appliances
indicates such data may still elicit useful insights on refractive error epidemiology.
This study was designed, therefore to examine whether optometric EMR data or spectacle
lens data can provide estimates of refractive error distribution that are comparable to tradi-
tional population surveys.
Methods
Anonymized EMR data was gathered from 28 Irish optometry practices. The data was
extracted remotely through the EMR provider following provision of explicit consent from the
data (practice) owners during the period of May 2018 to June 2019 for all 28 practices. This
study was approved by the TU Dublin Research Ethics and Integrity Committee and adheres
to the tenets of the Declaration of Helsinki (REC-18-124). Patient level consent was not
required due to the nature of the anonymization of the data. The data extracted comprised all
practice records since first use up to the date of extraction for each practice. The EMR provider
removed any personally identifying data and anonymized the data prior to delivery so that the
anonymization could not be reversed by the researchers. The data was analysed using the R
programming language (R Core Team (2020). R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/.). At the time of extraction, a new unique identifying number was generated for
each subject within the EMR data allowing their data to be tracked across multiple visits. The
data available for each subject included demographic, refractive, visual acuity, binocular vision,
contact lens, ocular health and clinical management data. For this analysis only demographic,
refractive and visual acuity data were considered with most refractions having been performed
as non-cycloplegic subjective refractions.
Anonymized patient spectacle lens sales data was provided by a major European manufac-
turer. This comprised lenses that had been manufactured and dispatched after an order was
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received from a practitioner with the majority of lenses for delivery within Europe. The data
was collated into histogram data using the SQLite database engine (Hipp, Wyrick & Company,
Inc., Charlotte, North Carolina, USA) and analysed using the R statistical programming lan-
guage. The data provided included the spherical power, cylindrical power and axis of the spec-
tacle prescription. The lens design, diameter, laterality (prescribed for right or left eye) and
date of manufacture were also included. For lens designs with an addition, this was also speci-
fied. The presence of an addition allowed the lenses to be separated into two groups, the single
vision (SV) lens group and the addition (ADD) lens group. The data was validated for missing
and malformed data fields and any lenses with incomplete or invalid data were excluded. The
spherical equivalent power was calculated for each lens.
Data from the E3 study was extracted by digitizing the published results using Plot Digitiser
[26]. Data from the GHS study [27], a population based observational study, was also digitized
as an additional comparison. The GHS was chosen as an additional comparison as it took
place in Germany, had a similar age range (35–74) and was one of the component studies of
the E3 study. In addition, Germany was the largest contributor to the spectacle lens data.
Myopia was defined according to the International Myopia standards [28], with a spherical
equivalent (SE) refractive error of� -0.50 D being considered myopic, and� -6.00 D consid-
ered highly myopic. Hyperopia was defined as� +0.75 D and emmetropia defined as> -0.50
D and < +0.75 D. For comparison with the E3 study, analysis was also performed using the
myopia definition used in that study, i.e.� -0.75 D.
The E3 study, a meta-analysis on refractive error prevalence in Europe, was chosen as a
comparative study for several reasons. Firstly, the manufacturer database reflected almost
exclusively European lens sales. Secondly, as the spectacle lens data comprised a substantial
proportion of reading addition lenses typically used by older presbyopic adults [29] (age� 40–
45 typically) [30], the adult age profile of the E3 consortium (age 25–89 years) was deemed
suitable, and it was assumed that the datasets could be comparable. These age assumptions
were also validated using the EMR data. With this more detailed optometric data, both the age
and spectacle correction data were available, allowing determination of the age distribution of
patients with single vision and reading addition spectacles. The relationship between age and
reading addition was determined by fitting a logistic function to the age and right eye reading
addition found in the EMR data using the ‘drc’ extension package for R [31]. A logistic func-
tion was also created to determine the number of individuals requiring a reading addition at
each age from 1 to 100 years old within the EMR data. The base R predict function was then
used to generate 95% prediction intervals for both logistic models. Probability density func-
tions were generated for each reading addition value to determine the distribution of age asso-
ciated with that reading addition. The ADD lens group then had an estimated age assigned for
each spectacle lens based on the reading addition value for that lens using the probabilities
generated from the EMR data.
The EMR data was randomly sampled to provide an age and gender matched population
for comparison with the E3 population. The ADD lens data was also age matched with the E3
population using the estimated age for each lens. From the age matched EMR and ADD lens
data, the proportion of myopia, high myopia and hyperopia present was calculated in 5-year
age brackets to allow comparison with the E3 and GHS data.
Results
Spectacle lens dispensing and EMR refractive error distribution
The spectacle lens dataset comprised 141,547,436 lenses from the manufacturer sales records
ranging from the year 1998 to 2016. The EMR dataset included 555,528 patient visits ranging
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from the year 1980 to 2019. Records with incomplete or missing data were excluded from both
datasets and only years with complete data were included in the analysis (Fig 1). In total
134,280,063 spectacle lenses were included, comprised of 84,561,994 SV lenses and 49,709,191
ADD lenses. The final EMR dataset was composed of 524,868 patient visits.
Over 97% of spectacle lenses were for delivery within Europe with Germany accounting for
the largest proportion (�48%) of all lenses delivered. The EMR data included 244,002 unique
patients representing 5.1% of the population of the Republic of Ireland [32]. The gender distri-
bution of EMR patient visits was 51.3% female, 34.9% male and not recorded in 13.8% of rec-
ords. The 28 optometric practices were located all across the Republic of Ireland representing
both rural and urban populations.
The distribution of refractive error within the EMR data and spectacle lens data are pre-
sented in Fig 2, including the complete datasets and also segregated according to lens type (SV
or ADD lens). Table 1 summarises the descriptive statistics for each distribution.
All distributions demonstrate the classic negatively skewed leptokurtotic curve found in
most studies of refractive error, with the majority of observations centred close to emmetropia.
The only exception to this pattern was the SV spectacle lenses which were found to have a
bimodal distribution with a significant notch apparent at zero spherical equivalent.
Estimating age using reading addition
Fig 3 shows the relationship between age and the presence of an addition by comparing the
EMR distribution of SE for single vision prescriptions with those aged under 45 and the SE dis-
tribution of prescriptions with an addition and those aged 45 and over. It can be seen that the
distribution of SE for those under age 45 (left panel, histogram bars) is very similar to the dis-
tribution of those prescribed a SV lens (left panel, dashed line), while the distribution of SE for
those over age 45 (right panel, histogram bars) is very similar to the distribution of those pre-
scribed an ADD lens (right panel, dashed line). The remarkable degree of similarity between
being under age 45 and being prescribed single vision (χ2 = 552, p = 0.2365, DoF = 529) and
being 45 years or older and being prescribed an addition (χ2 = 899, p = 0.2408, DoF = 870)
indicates that age and the prescribing of an addition are highly correlated. Table 2 shows the
relationship between age and the likelihood of prescribing a reading addition in the form of a
Fig 1. Number of spectacle lenses and EMR visits included in analysis.
https://doi.org/10.1371/journal.pone.0250468.g001
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contingency table. A summary of the distributions and their statistical relationship is given in
Table 3.
The relationship between age and the power of the addition given in glasses for the EMR
data is shown in Fig 4. This relationship could be accurately fitted to a logistic function with
nonlinear regression (estimate = 2.2 D, t = 818.94, p< 0.001). The residual standard error
found was 7.56 years.
Fig 4 also shows the 95% prediction limits for estimating age if only the spectacle add power
is known, as is the case with lens dispensing data. A logistic function was also fitted to the
Fig 2. Distribution of spherical equivalent in each dataset. Top Panel—EMR data from Irish optometry practices. Right spherical equivalent distribution for all visits
(n = 536,249), single vision prescriptions (n = 215,207) and addition prescriptions (n = 321,013). Bottom Panel—Spectacle Lens Distribution from manufacturer data
for all lenses (n = 134,280,063), single vision, (SV) lenses (n = 84,561,994) and addition, (ADD) lenses (n = 49,709,191).
https://doi.org/10.1371/journal.pone.0250468.g002
Table 1. Mean, range and distribution characteristics of spectacle lens and EMR data.
Dataset Mean SE (D) ± SD Skew Kurtosis
All Spectacle Lenses +0.02 ± 3.08 -0.80 1.73
SV Lenses -0.03 ± 3.22 -0.74 1.47
ADD Lenses +0.11 ± 2.84 -0.89 2.20
All EMR Visits -0.13 ± 2.50 -0.74 3.19
Visits with SV Rx -0.91 ± 2.74 -0.30 2.09
Visits with Add Rx +0.39 ± 2.17 -1.09 5.82
https://doi.org/10.1371/journal.pone.0250468.t001
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relationship between the probability of being prescribed a reading addition and age (esti-
mate = 42.29 years, t = 653.73, p< 0.001). The residual standard error was 1.73%. This allows
estimation of the proportion of individuals at each age likely to require a reading addition (Fig
5). These relationships were then used to infer ages for the ADD lens data. This allowed the gen-
eration of sub-populations of a given age for comparison with the EMR, E3 and GHS data.
Using these two functions to determine age ranges and by generating probability density func-
tions for each value of reading addition in the EMR data, the level of myopia, hyperopia and
astigmatism was calculated for age groups from�45 years to� 80 years for the ADD lens data.
Comparison with E3
The distributions of spherical equivalent refraction in the E3 study and the age matched EMR
data were closely matched (χ2 = 527, p = 0.29, DoF = 510) with both being negatively skewed
leptokurtotic distributions (Fig 6).
Fig 3. Age and the prescribing of an addition are highly correlated in EMR patients. Distribution of spherical equivalent for those under age 45 (left panel bars) and
those age 45 and over (right panel bars). The dotted line represents the distribution of spherical equivalent for those given a single vision prescription (left panel) and
those given a prescription containing an addition (right panel).
https://doi.org/10.1371/journal.pone.0250468.g003
Table 2. Contingency table comparing the frequency of addition prescribing for EMR patients under age 45 and
those age 45 and over.
No Addition Prescribed Addition Prescribed
Under 45 204,027 24,512
Age 45 or Over 13,515 298,807
https://doi.org/10.1371/journal.pone.0250468.t002
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Age-matched comparison of the level of myopia, hyperopia and astigmatism for EMR rela-
tive to E3 data revealed broadly similar distributions across the refractive error types, albeit
that the distribution of myopia was lower and hyperopia higher in the EMR data relative to the
E3 data (Table 4). The ADD lens data distributions of myopia, hyperopia and astigmatism
were all higher but also similar to the age matched E3 data (Table 5).
The E3 reported levels of myopia, hyperopia and high myopia across various age groups
were compared to the EMR, ADD lenses and GHS data across the same age groups (Figs 7–9).
These figures show the EMR data is the closest match to the E3 data. Confidence intervals for
the EMR data were found to be overlapping with the confidence intervals for E3 data at 7 age
points for myopic refractions (Fig 7), 6 age points for hyperopic refractions (Fig 8) and 12 age
points for highly myopic refractions (Fig 9). The ADD lens data, however, provides a closer
Table 3. Descriptive statistics comparing single vision EMR prescriptions to younger EMR patients and addition EMR prescriptions to older EMR patients.
Dataset Mean SE (D) Skew Kurtosis Chi-Square Test
Single Vision -0.91 ± 2.74 -0.30 2.09 χ2 = 552, p = 0.2365, DoF = 529
Under Age 45 -0.80 ± 2.66 -0.30 2.26
Addition +0.39 ± 2.17 -1.09 5.82 χ2 = 899, p = 0.2408, DoF = 870
Over Age 45 +0.36 ± 2.25 -1.16 5.58
https://doi.org/10.1371/journal.pone.0250468.t003
Fig 4. Predicted age based on the prescribed reading addition for EMR patients with 95% prediction intervals.
https://doi.org/10.1371/journal.pone.0250468.g004
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approximation to the E3 data for total myopia compared to the GHS data, particularly up to
age 64 (Fig 7).
Discussion
Our results indicate that EMR data provides a close approximation to refractive error preva-
lence values found as part of the E3 study. Age related variation in the proportions of myopes
and hyperopes are similar across the EMR and E3 data. Both the EMR and E3 datasets demon-
strated high levels of myopia in younger age groups (Fig 7) which supports the findings of
other studies demonstrating an increase in myopia prevalence in more recent generations
[5,6]. Although the EMR data falls outside the E3 confidence intervals at some points for both
the myopia and hyperopia comparisons, this is also true of the GHS data which was a compo-
nent study of the E3 dataset, with the EMR data providing a closer match to the E3 than the
GHS data. As the confidence intervals indicate the likely position of the mean of the study pop-
ulation some fluctuation is expected when comparing different study populations.
It was possible to estimate the likely recipient age for every spectacle lens prescription con-
taining a reading addition by using the EMR data. This was achieved based on the observation
that a significant majority of EMR patient visits below the age of 40 years were not prescribed
an addition while the majority of patients visits above the age of 50 years were prescribed an
addition. Along with the presence of an addition, the power of the reading addition was also
Fig 5. Likelihood of needing a reading addition for EMR patients at different ages with 95% prediction intervals.
https://doi.org/10.1371/journal.pone.0250468.g005
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found to provide a means of estimating a patient’s age. These inferences allowed an estimated
age to be associated with each spectacle lens containing an addition within the spectacle lens
sales dataset. The combination of disparate data sources to provide greater insight is a hallmark
of Big Data analysis [33], and in this case allowed a deeper understanding of the usefulness of
the spectacle lens sales data as a source of epidemiological data of refractive error.
Having accurate and current information on the prevalence of refractive error is vital to
allow health services to plan for the increasing need for optical correction and the increased
burden due to the ocular comorbidities [3,34–37] associated with increasing refractive error.
Myopia is of particular concern as it is estimated that up to 49.8% of the global population will
be myopic by 2050 and 9.8% of those will be highly myopic [4]. The combination of high myo-
pia and increasing age have been found to be a risk factor for vision impairment and blindness
Fig 6. Comparison of spherical equivalent distribution between E3 and EMR. E3 distribution of refractive error spherical equivalent (dotted line) compared to the
gender and age matched EMR distribution of right eye refractive error spherical equivalent (bars).
https://doi.org/10.1371/journal.pone.0250468.g006
Table 4. Age matched comparison of refractive error rates between the E3 consortium and EMR data (mean age = 60.16 ± 12.23 years).
Data Set All Myopia
� -0.75
Low Myopia�
-0.75 to > -3.00
Moderate Myopia












30.60% 19.50% 8.08% 2.71% 25.23% 5.37% 44.17% 23.86%
EMR
(n = 200,076
21.52% 13.56% 5.70% 2.26% 37.89% 7.38% 40.59% 28.38%
https://doi.org/10.1371/journal.pone.0250468.t004
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[38]. A recent meta-analysis found a significantly increased risk of myopic macular degenera-
tion and retinal detachment in high myopes with reduced visual acuity and worse treatment
outcomes in eyes with these conditions [39]. Assessing any change to the prevalence of high
myopia within a population is the area of most concern when considering the ocular comor-
bidities associated with refractive error. EMR data contains refractive error information and
patient demographics including age, which can help to determine the population risk of vision
impairment. The EMR data provides a good match to the E3 study for high myopia (Fig 9) and
as such may be an invaluable method to determine the ongoing risk of vision impairment.
While conventional epidemiological studies remain the gold standard, they have some dis-
advantages. The most reliable studies have large sample sizes allowing their results to be
Table 5. Age matched comparison of refractive error rates between the E3 consortium and ADD lens data (mean age = 62.55 ± 8.59 years).
Data Set All Myopia
� -0.75
Low Myopia�
-0.75 to > -3.00
Moderate Myopia










-0.75 to < +1.00
Astigmatism� 1.00
E3 (n = 50,010) 22.44% 14.08% 6.24% 1.93% 37.23% 7.98% 40.33% 26.96%
ADD Lenses
(n = 35,720,655
28.60% 15.12% 9.52% 3.95% 43.02% 9.98% 28.38% 31.45%
https://doi.org/10.1371/journal.pone.0250468.t005
Fig 7. Total myopia proportion for all data sets as a function of age group. Total myopia proportion for EMR (inverted triangle), ADD Lenses (triangle), GHS
(circle) and E3 (square) data as a function of age group. The E3 data confidence intervals (dark shaded area) are plotted to illustrate comparison with the other data
sets. The EMR data confidence intervals (light shaded area) are plotted to show the overlap with the E3 data.
https://doi.org/10.1371/journal.pone.0250468.g007
PLOS ONE Application of big-data for epidemiological studies of refractive error
PLOS ONE | https://doi.org/10.1371/journal.pone.0250468 April 23, 2021 11 / 17
generalized to the entire population. Such sample sizes require significant investment and time
to conduct the study, which perhaps explains the relative lack of epidemiological studies of
refractive error and significant lack of longitudinal studies of refractive error. This paucity of
data also contributes to uncertainty with regards to future projections of myopia prevalence
[4]. Where such data is not available, EMR or industrial data may have a useful role as these
are increasingly being collected as a matter of routine and can be collected with greater ease
and at more regular intervals.
It is important to acknowledge that all epidemiological studies suffer from various forms of
bias. For example, it is well established that most cross sectional studies suffer from volunteer
bias, with volunteers usually from higher socio-economic backgrounds with a higher level of
education [40]. Longitudinal studies frequently suffer from loss to follow up which may induce
a bias in the profile of the remaining study population. It is important, therefore, when design-
ing an epidemiological survey of refractive error to attempt to minimise these biases. Big data
studies on refractive error will not suffer with the same biases as the data was not collected for
the purpose of determining the population burden of refractive error. This type of epidemio-
logical study will however, have a different set of biases which need to be considered. A fre-
quent criticism of the secondary use of EMR data concerns the lack of access to healthcare of
some population cohorts [41] due to a lack of health insurance. As this EMR data has come
Fig 8. Total hyperopia proportion for all data sets as a function of age group. Total hyperopia proportion for EMR (inverted triangle), ADD Lenses (triangle), GHS
(circle) and E3 (square) data as a function of age group. The E3 data confidence intervals (dark shaded area) are plotted to illustrate comparison with the other data
sets. The EMR data confidence intervals (light shaded area) are plotted to show the overlap with the E3 data.
https://doi.org/10.1371/journal.pone.0250468.g008
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from a jurisdiction with free access to eyecare which is widely availed of, this should not create
a significant bias in our data [42,43]. Less frequent replacement of spectacle lenses from those
of lower socio-economic backgrounds may present a more significant issue with regards to the
spectacle lens dispensing data. Measurement error can exist as a bias in any epidemiological
study but may be well controlled in small studies through standardization of equipment and
procedures. In a Big Data study of this nature, this is not possible. Nevertheless, error rates of
subjective refraction in adults are typically low at between 1% and 2%, indicating the vast
majority of refractions should be accurate to within ± 0.50 D of the correct refraction [44,45].
There are several limitations to this study that must be considered. In relation to spectacle
lens data, demographic information of the individuals purchasing the spectacle lenses is not
typically available in industrial datasets. Geographic information is likely to be available, how-
ever, which can provide some useful information. Using the EMR data to infer the age of a
cohort of the spectacle lens users enhances the usefulness of this data, but the overall lack of
demographic information means that further conclusions on subpopulations cannot be
drawn. In this study, the spectacle lens data was supplied by one manufacturer. Economic fac-
tors and market penetration may have an effect on the background of the consumer choosing
lenses from this manufacturer. Industrial data could be biased, for example, to particular
socio-economic, ethnic or other demographic subgroups for reasons such as product cost,
Fig 9. Total high myopia proportion for all data sets as a function of age group. Total high myopia proportion for EMR (inverted triangle), ADD Lenses (triangle)
and E3 (square) data as a function of age group. The E3 data confidence intervals (dark shaded area) are plotted to illustrate comparison with the other data sets. The
EMR data confidence intervals (light shaded area) are plotted to show the overlap with the E3 data. GHS not present as high myopia data was unavailable.
https://doi.org/10.1371/journal.pone.0250468.g009
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geographic location and other factors specific to individual manufacturers. Higher educational
attainment is associated with both socio-economic status and myopia [6], for example, so the
possibility that the oversampling of individuals from particular backgrounds within individual
datasets might influence population estimates of refractive error needs to be considered.
Under sampling of emmetropic patients is a more significant issue for the spectacle lens data
as these represent spectacle lens sales. This will tend to produce an apparent increased propor-
tion of hyperopic and myopic refractive errors, especially for younger subjects, as observed in
this study. It is unlikely that emmetropic patients are purchasing spectacle lenses in significant
numbers. This is particularly evident when considering the SV lenses in Fig 3. The notch appar-
ent at zero dioptric power represents the reduction in purchasing of spectacle lenses by this
group. It might be expected that the number of zero power lenses would be smaller than was
observed, but there are plausible reasons to explain this. In cases of anisometropia one eye may
have a zero-power lens when the fellow eye needs correction. In addition, the computation of
spherical equivalent may result in zero spherical equivalent power for lenses prescribed to
patients with mixed astigmatism. The lack of emmetropes represented within the spectacle lens
sales data presents a problem and may explain the poorer match to the E3 study relative to EMR
data. This implies that such data may be more representative of the distribution of refractive
error within a population above a certain threshold of refractive error. The greatest risks of visual
impairment are associated with high levels of myopia [39], and also high levels of hyperopia [3],
both categories likely to seek optical correction. Further analysis and modelling may remove the
limitation associated with the under sampling of emmetropes and allow the determination of the
risk of vision impairment in those using spectacle lenses to correct higher refractive errors.
There are less limitations applicable to the EMR data due to the increased demographic
detail captured in this data. Under sampling of emmetropic patients is likely to be less prob-
lematic for the EMR data which includes refraction data found as part of a patient’s eye exami-
nation. Emmetropic patients are still likely to attend routine eye examinations for the purposes
of screening for common ocular pathologies such as glaucoma and cataract [46] although
some under sampling of young emmetropic patients may have still occurred. Importantly,
EMR data is likely to be highly representative of the older population given the almost univer-
sal need for optical correction as presbyopia begins to manifest as a problem, even for emme-
tropes and low hyperopes who did not previously need correction. This is particularly the case
in most countries in Europe where subsidised eye examinations are accessible to the majority
of the population [47]. The close match of the EMR and E3 data observed herein suggests that
the EMR is representative of the population at large.
In this EMR dataset, it was not possible to tell what type of refraction had been performed
to reach the refractive error prescribed. Cycloplegic refraction is performed to avoid the errors
in refraction that can be induced by accommodation in children and the use of cycloplegia is
considered the most appropriate method to assess refractive error for research purposes [48].
Although it is unknown how many of these refractions have been performed with the aid of
cycloplegia, a significant number of epidemiological surveys on refractive error have been car-
ried out without the use of cycloplegia [7]. It has been found that accommodation mostly
affects the determination of refractive error in children and has little impact on adults [49,50],
particularly older adults [51]. The technique of refraction used, therefore, should have little
impact on the primarily adult dataset used herein.
Conclusion
The prevalence of refractive error within a population can be estimated using EMR data in the
absence of population surveys. Results from EMR data also allow age to be inferred from the
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addition in a spectacle lens. Industry derived sales can then be used to provide insights on the
epidemiology of refractive errors in a population over certain age ranges. EMR and industrial
data may therefore provide a fast and cost-effective surrogate measure of refractive error distri-
bution that can be used for future health service planning purposes.
Author Contributions
Conceptualization: Michael Moore, James Loughman, Daniel I. Flitcroft.
Data curation: Michael Moore.
Formal analysis: Michael Moore, John S. Butler, Daniel I. Flitcroft.
Investigation: Michael Moore, Daniel I. Flitcroft.
Methodology: Michael Moore, Daniel I. Flitcroft.
Project administration: James Loughman.
Resources: James Loughman, Arne Ohlendorf, Siegfried Wahl.
Software: Michael Moore, Daniel I. Flitcroft.
Supervision: James Loughman, John S. Butler, Daniel I. Flitcroft.
Validation: Michael Moore, John S. Butler, Daniel I. Flitcroft.
Visualization: Michael Moore.
Writing – original draft: Michael Moore.
Writing – review & editing: James Loughman, John S. Butler, Arne Ohlendorf, Siegfried
Wahl, Daniel I. Flitcroft.
References
1. Bourne RRA, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, et al. Causes of vision loss world-
wide, 1990–2010: a systematic analysis. Lancet Glob Heal. 2013; 1: e339–e349. https://doi.org/10.
1016/S2214-109X(13)70113-X PMID: 25104599
2. Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, et al. Causes of Blindness and Visual Impairment in Urban and
Rural Areas in Beijing. The Beijing Eye Study. Ophthalmology. 2006; 113: 1134.e1–1134.e11. https://
doi.org/10.1016/j.ophtha.2006.01.035 PMID: 16647133
3. Lavanya R, Kawasaki R, Tay WT, Cheung CMC, Mitchell P, Saw SM, et al. Hyperopic refractive error
and shorter axial length are associated with age-related macular degeneration: The Singapore Malay
eye study. Investig Ophthalmol Vis Sci. 2010; 51: 6247–6252. https://doi.org/10.1167/iovs.10-5229
PMID: 20671287
4. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global Prevalence of Myo-
pia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016; 1–7. https://
doi.org/10.1016/j.ophtha.2016.01.006 PMID: 26875007
5. Vitale S, Sperduto RD, Ferris FL. Increased prevalence of myopia in the United States between 1971–
1972 and 1999–2004. Arch Ophthalmol (Chicago, Ill 1960). 2009; 127: 1632–9. https://doi.org/10.1001/
archophthalmol.2009.303 PMID: 20008719
6. Williams KM, Bertelsen G, Cumberland P, Wolfram C, Verhoeven VJM, Anastasopoulos E, et al.
Increasing Prevalence of Myopia in Europe and the Impact of Education. Ophthalmology. 2015; 122:
1489–97. https://doi.org/10.1016/j.ophtha.2015.03.018 PMID: 25983215
7. Pan C, Ramamurthy D, Saw S. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol
Opt. 2012; 32: 3–16. https://doi.org/10.1111/j.1475-1313.2011.00884.x PMID: 22150586
8. Lin LLK, Shih YF, Hsiao CK, Chen CJ. Prevalence of myopia in Taiwanese schoolchildren: 1983 to
2000. Ann Acad Med Singapore. 2004; 33: 27–33. Available: http://www.ncbi.nlm.nih.gov/pubmed/
15008558. PMID: 15008558
PLOS ONE Application of big-data for epidemiological studies of refractive error
PLOS ONE | https://doi.org/10.1371/journal.pone.0250468 April 23, 2021 15 / 17
9. Cortinez MF, Chiappe JP, Iribarren R. Prevalence of Refractive Errors in a Population of Office-Workers
in Buenos Aires, Argentina. Ophthalmic Epidemiol. 2008; 15: 10–16. https://doi.org/10.1080/
09286580701755560 PMID: 18300084
10. Ferraz FH, Corrente JE, Opromolla P, Padovani CR, Schellini SA. Refractive errors in a Brazilian popu-
lation: age and sex distribution. Ophthalmic Physiol Opt. 2015; 35: 19–27. https://doi.org/10.1111/opo.
12164 PMID: 25345343
11. Mashige KP, Jaggernath J, Ramson P, Martin C, Chinanayi FS, Naidoo KS. Prevalence of Refractive
Errors in the INK Area, Durban, South Africa. Optom Vis Sci. 2016; 93: 243–50. https://doi.org/10.1097/
OPX.0000000000000771 PMID: 26760577
12. Williams KM, Verhoeven VJM, Cumberland P, Bertelsen G, Wolfram C, Buitendijk GHS, et al. Preva-
lence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium. Eur J Epidemiol.
2015; 30: 305–315. https://doi.org/10.1007/s10654-015-0010-0 PMID: 25784363
13. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health
Econ. 1996; 5: 513–524. https://doi.org/10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.
CO;2-9/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2–9 PMID: 9003938
14. Phillips C V. The economics of “more research is needed.” Int J Epidemiol. 2001; 30: 771–776. https://
doi.org/10.1093/ije/30.4.771 PMID: 11511601
15. Mooney SJ, Westreich DJ, El-Sayed AM. Epidemiology in the era of big data. Epidemiology. 2015; 26:
390–394. https://doi.org/10.1097/EDE.0000000000000274 PMID: 25756221
16. Food US and Administration Drug. Examining the Impact of Real-World Evidence on Medical Product
Development. Natl Acad Sci Eng Med. 2018. https://doi.org/10.17226/25352 PMID: 30964617
17. Donthineni PR, Kammari P, Shanbhag SS, Singh V, Das AV, Basu S. Incidence, demographics, types
and risk factors of dry eye disease in India: Electronic medical records driven big data analytics report I.
Ocul Surf. 2019; 17: 250–256. https://doi.org/10.1016/j.jtos.2019.02.007 PMID: 30802671
18. Willis JR, Vitale S, Morse L, Parke DW, Rich WL, Lum F, et al. The Prevalence of Myopic Choroidal
Neovascularization in the United States: Analysis of the IRIS®Data Registry and NHANES. Ophthal-
mology. 2016; 123: 1771–1782. https://doi.org/10.1016/j.ophtha.2016.04.021 PMID: 27342789
19. Lee AY, Lee CS, Butt T, Xing W, Johnston RL, Chakravarthy U, et al. UK AMD EMR USERS GROUP
REPORT V: Benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better
than 6/12. Br J Ophthalmol. 2015; 99: 1045–1050. https://doi.org/10.1136/bjophthalmol-2014-306229
PMID: 25680619
20. Willis J, Morse L, Vitale S, Parke DW, Rich WL, Lum F, et al. Treatment Patterns for Myopic Choroidal
Neovascularization in the United States: Analysis of the IRIS Registry. Ophthalmology. 2017; 124: 935–
943. https://doi.org/10.1016/j.ophtha.2017.02.018 PMID: 28372860
21. Verhoeven VJM, Hysi PG, Wojciechowski R, Fan Q, Guggenheim JA, Höhn R, et al. Genome-wide
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